Vertebral deformities in osteogenesis imperfecta : EEEffects of i.v. neridronate therapy in children and adolescents;Wirbelkörperkompressionen bei Osteogenesis imperfecta : Wirksamkeit der i.v. Neridronattherapie bei Kindern und Jugendlichen

Monatsschrift fur Kinderheilkunde

Volumn 157, Issue 12, 2009, Pages 1237-1241

  Beccard, R ^a   Fricke, O ^a   Land, C ^b   Semler, O ^a   Korber F ^a   Stabrey, A ^a   Schonau E ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Endokrinologikum   (Germany)

Author keywords

Bisphosphonates; Lumbar vertebrae; Neridronate; Osteogenesis imperfecta; Quantitative vertebral morphometry

Indexed keywords

NERIDRONIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; INFANT; LUMBAR VERTEBRA; MALE; MORPHOMETRICS; OSTEOGENESIS IMPERFECTA; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT OUTCOME; VERTEBRA MALFORMATION;

EID: 77249098733     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-009-1991-0     Document Type: Article

References (22)

1. Adami S, Zamberlan N (1996) Adverse effects of bisphosphonates: a comparative review. Drug Sa¬fety 14:158-170
2. Adami S, Bhalla AK, Dorizzi R et al (1987) The acute-phase response after bisphosphonate admi¬nistration. Calcif Tissue 41:326-331
3. Antoniazzi F, Zamboni G, Lauriola S et al (2006) Early bisphosphonate treatment in infants with se¬vere osteogenesis imperfecta. J Pediatr 149:174-179
4. Astrom E, Soderhall S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356-364
5. Byers PH (2005) Splice site mutations in type I col¬lagen genes and their outcomes. 9th International Meeting on Osteogenesis imperfecta, Annapolis, Maryland, USA
6. Engelbert RH, Uiterwaal CS, Gerver WJ et al (2004) Osteogenesis imperfecta in childhood: impair¬ment and disability. A prospective study with 4-year follow-up. Arch Phys Med Rehabil 85:772-778
7. Gatti D, Antoniazzi F, Prizzi R et al (2005) Intrave¬nous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 20(5):758-763
8. Glorieux FH (2007) Treatment of osteogenesis im¬perfecta: who, why, what? Horm Res [Suppl 5] 68:8-11
9. Glorieux FH, Bishop NJ, Plotkin H et al (1998) Cyc¬lic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339(14):947-962
10. Land C (2008) Zu viele Frakturen - Verdacht auf kindliche Osteoporose? Kinder Jugendmed 8:1-7
11. Land C, Rauch F, Montpetit K et al (2006) Effect of intravenous pamidronate therapy on functional abilities and level of amputation in children with osteogenesis imperfecta. J Pediatr 148:456-460
12. Land C, Rauch F, Munns CF et al (2006) Vertebral morphometry in children and adolescents with os¬teogenesis imperfecta: effect of intravenous pa¬midronate treatment. Bone 39:901-906 (Pubitemid 44311714)
13. Letocha AD, Cintas HL, Troendle JF et al (2005) Controlled trial of pamidronate in children with ty¬pes III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional im¬provement. J Bone Miner Res 20:977-986
14. Munns CF, Rauch F, Mier RJ, Glorieux FH (2004) Re¬spiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone 35:231-234
15. Munns CF, Rauch F, Travers R, Glorieux FH (2005) Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 20:1235-1243
16. Pollitt R, Mc Mahon R, Nunn J et al (2005) Mutation analysis of COL1A1 and COL1A2 in a cohort of pati¬ents with osteogenesis imperfecta. British Human Genetics Conference, York
17. Rauch F, Glorieux FH (2004) Osteogenesis imper¬fecta. Lancet 363(9418):1377-1385
18. Rauch F, Plotkin H, Zeitlin L, Glorieux FH (2003) Bo¬ne mass, size and density in children and adoles¬cents with osteogenesis imperfecta: effect of in¬travenous pamidronate therapy. J Bone Miner Res 18:610-614 (Pubitemid 36899310)
19. Rauch F, Schönau E, Glorieux FH (2000) Bisphos¬phonate - Anwendung in der Pädiatrie. Monats¬schr Kinderheilkd 148:334-341
20. Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bo¬ne tissue of children and adolescents with osteo¬genesis imperfecta. J Clin Invest 110:1293-1299
21. Sillence DO (1988) Osteogenesis imperfecta noso¬logy and genetics. Ann N Y Acad Sci 543:1-15
22. Sumnik Z, Land C, Rieger-Wettengl G et al (2004) Effects of pamidronate treatment on vertebral de¬formity in children with primary osteoporose. Horm Res 61(3):127-142